Neurologic manifestations of chronic methamphetamine abuse
- PMID: 23688691
- PMCID: PMC3764482
- DOI: 10.1016/j.psc.2013.02.005
Neurologic manifestations of chronic methamphetamine abuse
Abstract
The drug with perhaps the greatest impact on the practice of Psychiatry is Methamphetamine. By increasing the extracellular concentrations of dopamine while slowly damaging the dopaminergic neurotransmission, Meth is a powerfully addictive drug whose chronic use preferentially causes psychiatric complications. Chronic Meth users have deficits in memory and executive functioning as well as higher rates of anxiety, depression, and most notably psychosis. It is because of addiction and chronic psychosis from Meth abuse that the Meth user is most likely to come to the attention of the practicing Psychiatrist/Psychologist. Understanding the chronic neurologic manifestations of Meth abuse will better arm practitioners with the diagnostic and therapeutic tools needed to make the Meth epidemic one of historical interest only.
Copyright © 2013 Elsevier Inc. All rights reserved.
References
-
- Streatfeild D. Cocaine: an unauthorized biography. New York: Picador; 2001.
-
- Nagai T, Kamiyama S. Forensic toxicologic analysis of methamphetamine and amphetamine optical isomers by high performance liquid chromatography. Int J Legal Med. 1988;101:151–9. - PubMed
-
- Nagai H. Studies on the components of Ephedraceae in herb medicine. Yahugaku Zasshi. 1893;139:901–33.
-
- Miller MA. History and epidemiology of amphetamine abuse in the United States. In: Klee H, editor. Amphetamine misuse: international perspectives on current trends. Reading (UK): Harwood Academic Publishers; 1997. pp. 113–33.
-
- Anglin MD, Burke C, Perrochet B, et al. History of the methamphetamine problem. J Psychoactive Drugs. 2000;32:137–41. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
